Uh Oh, We've Lost That Page!
We're sorry...
You'll probably be able to find what you want by visiting the Home page. We'll try not to let that happen again.
New Stories
-
A new prostate cancer technology moves closer to global trials after strong early results
March 12, 2026 - - Latest News -
Cell therapy company Mesoblast names executive to guide clinical development and medical affairs
March 12, 2026 - - Latest News -
Patrys moves toward first human trial for injectable delirium therapy
March 12, 2026 - - Latest News -
Imugene launches $20 million capital raise to fund expansion of Azer Cel trials
March 12, 2026 - - Latest News -
CSL expands US manufacturing with $1.5bn investment to boost plasma therapy production
March 10, 2026 - - Latest News -
Telix Phase 3 cancer study shows encouraging safety results for novel radiotherapy
March 10, 2026 - -
Imugene reports strong early results in Azer-Cel cancer clinical trial
March 10, 2026 - - Latest News